Robinson, Reeder M.
Basar, Ashton P.
Reyes, Leticia
Duncan, Ravyn M.
Li, Hong
Dolloff, Nathan G. http://orcid.org/0000-0002-9181-2180
Funding for this research was provided by:
National Cancer Institute (R01CA245081, R42CA213488)
Article History
Received: 20 December 2021
Accepted: 10 March 2022
First Online: 5 April 2022
Declarations
:
: N.G.D. owns equity in Leukogene Therapeutics, Inc. N.G.D. and R.M.R. are inventors on patents.